New telehealth program aims to ease the burden of advanced cancer for patients and families

NCT ID NCT06936878

Recruiting now Symptom relief Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program called BOLSTER, which offers six telehealth sessions with a nurse to help patients with advanced gynecologic or gastrointestinal cancers and their care partners build skills, manage symptoms, and cope with challenges. Participants also get access to a website with personalized educational materials. The goal is to see if the program improves quality of life and well-being for both patients and caregivers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BOLSTER Program (behavioral intervention: telehealth sessions and website)
What this could lead to: If it works, this program could provide a practical way to improve quality of life and coping skills for patients with advanced cancer and their caregivers.
What could go wrong: This is a behavioral support study, not a treatment for cancer itself. It may not reduce symptoms or improve well-being for everyone, and results depend on participant engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer digestive system cancer digestive system neoplasm female reproductive organ cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED CANCER GASTROINTESTINAL CANCER GYNECOLOGIC CANCER

Contacts and locations

Locations

Dana-Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States
The University of Texas MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.